(Q42694005)

English

Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial

scientific article published on March 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

phase II clinical trial

0 references

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

Julio Rosenstock

9

object named as

Julio Rosenstock

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1

object named as

Bernard Zinman

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Chantal Mathieu

11

object named as

Chantal Mathieu

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

10

object named as

Michel Pinget

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

author name string

Greg Fulcher

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Paturi V Rao

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Nihal Thomas

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Lars A Endahl

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Thue Johansen

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Rebecka Lindh

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Andrew Lewin

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

language of work or name

0 references

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

377

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

9769

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

924-931

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962305-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962305-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962305-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Is glycemic control improving in U.S. adults?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962305-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962305-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Good glycaemic control: an international perspective on bridging the gap between theory and practice in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962305-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962305-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962305-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962305-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962305-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluating risk factors associated with severe hypoglycaemia in epidemiology studies-what method should we use?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962305-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The physiologic replacement of insulin. An elusive goal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962305-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962305-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962305-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Refining basal insulin therapy: what have we learned in the age of analogues?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962305-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(10)62305-7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42694005&oldid=2182043807"